IP Library Granted Patent US 12,514,971
Granted Patent B2
US 12,514,971 · App. 17/791,329 · Granted Jan 6, 2026

Systems and methods for controlling fluid instillation therapy using pH feedback

Inventors: Justin Alexander Long (Lago Vista, TX); Christopher Brian Locke (Bournemouth, GB)
Assignee: KCI Manufacturing Unlimited Company
A61M1/95A61B5/14539A61B5/445A61B5/7275A61B5/746A61F13/05A61M1/912A61M1/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,514,971
App. No.
17/791,329
Granted
Jan 6, 2026
Kind
B2
Abstract

Systems, apparatuses, and methods for providing negative pressure with instillation fluids to a tissue site are disclosed. Some embodiments are illustrative of an apparatus or system for delivering negative-pressure and/or therapeutic solution of fluids to a tissue site, which can be used in conjunction with sensing properties of fluids extracted from a tissue site and/or instilled at a tissue site. For example, a system may comprise a tissue interface adapted to be coupled to a source of instillation fluid and a dressing interface having a therapy cavity that includes a pH sensor to provide data indicative of acidity/alkalinity at the tissue site. Such apparatus may further comprise algorithms for processing such data for providing information relating to the progression of healing of wounds at the tissue site.

Claims (46)

1 . A system for controlling negative pressure and instillation therapy at a tissue site based on properties of wound fluids, the system comprising:

a tissue interface adapted to be disposed at the tissue site and adapted to be coupled to a source of instillation fluid;

a cover configured to seal the tissue interface and create a therapeutic environment proximate to the tissue site; and

a dressing interface configured to couple to the cover opposite the tissue interface to couple a source of negative-pressure to the tissue interface, the dressing interface comprising:

a housing having a therapy cavity including an opening configured to be disposed in fluid communication with the tissue interface, and a negative-pressure port adapted to fluidly couple the therapy cavity to the source of negative-pressure;

a pH sensor in fluid communication with the therapy cavity and configured to sense pH of the wound fluids; and

a processing element electrically coupled to the pH sensor for receiving property signals indicative of the pH of the wound fluids, the processing element being further configured to assess health characteristics of the tissue site based on the pH of the wound fluids, modify the instillation therapy in response to the pH measured, and provide a fluid-filled alarm when the pH of the wound fluids at the tissue site changes in proportion to a volume of instillation fluid delivered to the tissue site and reaches a value corresponding to a filled-volume of the tissue interface.

2 . The system of claim 1 , wherein the processing element is further configured to modify the instillation therapy.

3 . The system of claim 1 , wherein the processing element is further configured to compare the pH of the wound fluids to a target pH range.

4 . The system of claim 3 , wherein the pH of the wound fluid is modulated by delivering instillation fluids to the tissue site that comprises any instillation fluid selected from a group of phosphate buffered saline, acetic acid, and soluble salts.

5 . The system of claim 4 , wherein the pH of the wound fluid is modulated further by varying a concentration of the selected instillation fluid.

6 . The system of claim 1 , further comprising a second pH sensor disposed at a second location between the negative-pressure port and the source of negative-pressure, and a second processing element electrically coupled to the second pH sensor for receiving a second property signal indicative of the pH of the wound fluids at the second location, the processing element being further configured to assess the health characteristics of the tissue site based on the pH of the wound fluids at the second location and modify the instillation therapy in response to the pH measured.

7 . The system of claim 6 , wherein the processing element assesses the health characteristics of the tissue site based on a comparison of the pH of the wound fluids at the tissue site and the pH of the wound fluids at the second location, and modifying the instillation therapy in response to the comparison.

8 . The system of claim 7 , wherein the processing element is further configured to increase a dwell time of instillation fluid delivered to the tissue site if the pH of the wound fluids at the tissue site remains substantially the same while the pH of the wound fluids at the second location decreases.

9 . The system of claim 7 , wherein the processing element is further configured to increase a soak time of instillation fluid delivered to the tissue site if the pH of the wound fluids at the tissue site remains substantially the same while the pH of the wound fluids at the second location decreases.

10 . The system of claim 7 , wherein the processing element is further configured to provide a blockage alarm indicating that a flow of instillation fluid is inhibited when the pH of the wound fluid at the tissue site changes, but the pH of the wound fluid at the second location does not change.

11 . The system of claim 1 , wherein the system further comprises a controller configured to receive the property signals from the processing element and to assess property readings reflective of the property signals to identify flow characteristics of the system.

12 . The system of claim 11 , wherein the system further comprises an instillation pump configured to provide instillation fluid to the tissue interface, and a sensor electrically coupled to the controller.

13 . The system of claim 1 , wherein the therapy cavity further comprises a vent port adapted to fluidly couple the therapy cavity to a source of positive-pressure.

14 . The system of claim 13 , wherein the processing element is further configured to receive the property signals indicative of the pH from the processing element and to assess property readings reflective of the property signals to identify the health characteristics of the tissue site.

15 . The system of claim 14 , wherein the health characteristics of the system include a wound progression state within the system, and wherein the processing element is configured to provide an alarm indicative of the wound progression state based on the property signals.

16 . A method for treating a tissue site utilizing a system for providing negative pressure and fluid instillation therapy based on assessing properties of wound fluids at the tissue site, wherein the system comprises a tissue interface and a dressing interface having a housing including a therapy cavity, the method comprising:

positioning the tissue interface at the tissue site, the tissue interface adapted to be coupled to a source of instillation fluid;

positioning a cover adjacent the tissue interface to seal the tissue interface and create a therapeutic environment proximate to the tissue site;

positioning the dressing interface adjacent to the cover opposite the tissue interface such that the therapy cavity is in fluid communication with the tissue interface through the cover, the therapy cavity adapted to be coupled to a source of negative pressure;

delivering instillation fluid from the source of instillation fluid to the therapy cavity;

sensing pH of the wound fluids using a pH sensor mounted to the housing in fluid communication with the therapy cavity;

determining flow characteristics of the system by using a processing element electrically coupled to the pH sensor, wherein the processing element receives property signals indicative of the pH measured;

modifying the fluid instillation therapy in response to the pH measured; and

providing a fluid-filled alarm when the pH of the wound fluids at the tissue site changes in proportion to a volume of instillation fluid delivered to the tissue site and reaches a value corresponding to a filled-volume of the tissue interface.

17 . The method of claim 16 , further comprising:

transmitting the property signals to a controller within the system for assessing the flow characteristics of the system;

receiving the property signals by the controller;

assessing property readings reflective of the property signals to identify the flow characteristics of the system; and

sensing an instillation pump pressure of an instillation pump and an instillation duty cycle of the source of instillation, wherein the instillation pump pressure and the instillation duty cycle are provided by sensors electrically coupled to the controller.

18 . The method of claim 17 , further comprising using the controller to assess the property readings and provide an alarm identifying a fluid leak state as one of the flow characteristics when a duty cycle of the instillation pump increases and a humidity remains substantially the same.

19 . The method of claim 17 , further comprising using the controller to assess the property readings and provide an alarm identifying a fluid leak state as one of the flow characteristics when a duty cycle of the instillation pump remains substantially the same and a humidity increases but not to a predetermined threshold humidity.

20 . A system for controlling negative pressure and instillation therapy at a tissue site based on properties of wound fluids, the system comprising:

a tissue interface adapted to be disposed at the tissue site and adapted to be coupled to a source of instillation fluid;

a cover configured to seal the tissue interface and create a therapeutic environment proximate to the tissue site; and

a dressing interface configured to couple to the cover opposite the tissue interface to couple a source of negative-pressure to the tissue interface, the dressing interface comprising:

a housing having a therapy cavity including an opening configured to be disposed in fluid communication with the tissue interface, and a negative-pressure port adapted to fluidly couple the therapy cavity to the source of negative-pressure;

a first pH sensor in fluid communication with the therapy cavity and configured to sense pH of the wound fluids;

a second pH sensor disposed at a second location between the negative-pressure port and the source of negative-pressure;

a first processing element electrically coupled to the pH sensor for receiving property signals indicative of the pH of the wound fluids, the first processing element being further configured to assess health characteristics of the tissue site based on the pH of the wound fluids and modify the instillation therapy in response to the pH measured; and

a second processing element electrically coupled to the second pH sensor for receiving a second property signal indicative of the pH of the wound fluids at the second location, the processing element being further configured to assess the health characteristics of the tissue site based on the pH of the wound fluids at the second location and modify the instillation therapy in response to the pH of the wound fluids measured at the second location.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2024
From: KCI LICENSING, INC.
To: KCI MANUFACTURING UNLIMITED COMPANY
Reel/Frame 066064/0923 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION LISTED ON SCHEDULE OF IP RIGHTS ATTACHED TO ASSIGNMENT AT LINES 55: 71; 89; 116-129; AND 131 NEED TO BE DELETED PREVIOUSLY RECORDED AT REEL: 064788 FRAME: 0823. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 13, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064886/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064788/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2023
From: LONG, JUSTIN ALEXANDER; LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 064747/0878 →
Continuity (2)
Provisional Application 62960992 · Jan 14, 2020
Related Publication 20230347040A1 · Nov 2, 2023
References Cited (201)
US 1355846A · Rannells · 1920 [cited by applicant]
US 2547758A · Keeling · 1951 [cited by applicant]
US 2632443A · Lesher · 1953 [cited by applicant]
US 2682873A · Evans et al. · 1954 [cited by applicant]
US 2910763A · Lauterbach · 1959 [cited by applicant]
US 2969057A · Simmons · 1961 [cited by applicant]
US 3066672A · Crosby, Jr. et al. · 1962 [cited by applicant]
US 3367332A · Groves · 1968 [cited by applicant]
US 3520300A · Flower, Jr. · 1970 [cited by applicant]
US 3568675A · Harvey · 1971 [cited by applicant]
US 3648692A · Wheeler · 1972 [cited by applicant]
US 3682180A · McFarlane · 1972 [cited by applicant]
US 3826254A · Mellor · 1974 [cited by applicant]
US 4080970A · Miller · 1978 [cited by applicant]
US 4096853A · Weigand · 1978 [cited by applicant]
US 4139004A · Gonzalez, Jr. · 1979 [cited by applicant]
US 4165748A · Johnson · 1979 [cited by applicant]
US 4184510A · Murry et al. · 1980 [cited by applicant]
US 4233969A · Lock et al. · 1980 [cited by applicant]
US 4245630A · Lloyd et al. · 1981 [cited by applicant]
US 4256109A · Nichols · 1981 [cited by applicant]
US 4261363A · Russo · 1981 [cited by applicant]
US 4275721A · Olson · 1981 [cited by applicant]
US 4284079A · Adair · 1981 [cited by applicant]
US 4297995A · Golub · 1981 [cited by applicant]
US 4333468A · Geist · 1982 [cited by applicant]
US 4373519A · Errede et al. · 1983 [cited by applicant]
US 4382441A · Svedman · 1983 [cited by applicant]
US 4392853A · Muto · 1983 [cited by applicant]
US 4392858A · George et al. · 1983 [cited by applicant]
US 4419097A · Rowland · 1983 [cited by applicant]
US 4465485A · Kashmer et al. · 1984 [cited by applicant]
US 4475909A · Eisenberg · 1984 [cited by applicant]
US 4480638A · Schmid · 1984 [cited by applicant]
US 4525166A · Leclerc · 1985 [cited by applicant]
US 4525374A · Vaillancourt · 1985 [cited by applicant]
US 4540412A · Van Overloop · 1985 [cited by applicant]
US 4543100A · Brodsky · 1985 [cited by applicant]
US 4548202A · Duncan · 1985 [cited by applicant]
US 4551139A · Plaas et al. · 1985 [cited by applicant]
US 4569348A · Hasslinger · 1986 [cited by applicant]
US 4605399A · Weston et al. · 1986 [cited by applicant]
US 4608041A · Nielsen · 1986 [cited by applicant]
US 4640688A · Hauser · 1987 [cited by applicant]
US 4655754A · Richmond et al. · 1987 [cited by applicant]
US 4664662A · Webster · 1987 [cited by applicant]
US 4710165A · McNeil et al. · 1987 [cited by applicant]
US 4733659A · Edenbaum et al. · 1988 [cited by applicant]
US 4743232A · Kruger · 1988 [cited by applicant]
US 4758220A · Sundblom et al. · 1988 [cited by applicant]
US 4787888A · Fox · 1988 [cited by applicant]
US 4826494A · Richmond et al. · 1989 [cited by applicant]
US 4838883A · Matsuura · 1989 [cited by applicant]
US 4840187A · Brazier · 1989 [cited by applicant]
US 4863449A · Therriault et al. · 1989 [cited by applicant]
US 4872450A · Austad · 1989 [cited by applicant]
US 4878901A · Sachse · 1989 [cited by applicant]
US 4897081A · Poirier et al. · 1990 [cited by applicant]
US 4906233A · Moriuchi et al. · 1990 [cited by applicant]
US 4906240A · Reed et al. · 1990 [cited by applicant]
US 4919654A · Kalt · 1990 [cited by applicant]
US 4941882A · Ward et al. · 1990 [cited by applicant]
US 4953565A · Tachibana et al. · 1990 [cited by applicant]
US 4969880A · Zamierowski · 1990 [cited by applicant]
US 4985019A · Michelson · 1991 [cited by applicant]
US 5037397A · Kalt et al. · 1991 [cited by applicant]
US 5086170A · Luheshi et al. · 1992 [cited by applicant]
US 5092858A · Benson et al. · 1992 [cited by applicant]
US 5100396A · Zamierowski · 1992 [cited by applicant]
US 5134994A · Say · 1992 [cited by applicant]
US 5149331A · Ferdman et al. · 1992 [cited by applicant]
US 5167613A · Karami et al. · 1992 [cited by applicant]
US 5176663A · Svedman et al. · 1993 [cited by applicant]
US 5215522A · Page et al. · 1993 [cited by applicant]
US 5232453A · Plass et al. · 1993 [cited by applicant]
US 5261893A · Zamierowski · 1993 [cited by applicant]
US 5278100A · Doan et al. · 1994 [cited by applicant]
US 5279550A · Habib et al. · 1994 [cited by applicant]
US 5298015A · Komatsuzaki et al. · 1994 [cited by applicant]
US 5342376A · Ruff · 1994 [cited by applicant]
US 5344415A · DeBusk et al. · 1994 [cited by applicant]
US 5358494A · Svedman · 1994 [cited by applicant]
US 5437622A · Carion · 1995 [cited by applicant]
US 5437651A · Todd et al. · 1995 [cited by applicant]
US 5527293A · Zamierowski · 1996 [cited by applicant]
US 5549584A · Gross · 1996 [cited by applicant]
US 5556375A · Ewall · 1996 [cited by applicant]
US 5607388A · Ewall · 1997 [cited by applicant]
US 5636643A · Argenta et al. · 1997 [cited by applicant]
US 5645081A · Argenta et al. · 1997 [cited by applicant]
US 6071267A · Zamierowski · 2000 [cited by applicant]
US 6135116A · Vogel et al. · 2000 [cited by applicant]
US 6241747B1 · Ruff · 2001 [cited by applicant]
US 6287316B1 · Agarwal et al. · 2001 [cited by applicant]
US 6345623B1 · Heaton et al. · 2002 [cited by applicant]
US 6488643B1 · Tumey et al. · 2002 [cited by applicant]
US 6493568B1 · Bell et al. · 2002 [cited by applicant]
US 6553998B2 · Heaton et al. · 2003 [cited by applicant]
US 6814079B2 · Heaton et al. · 2004 [cited by applicant]
US 7846141B2 · Weston · 2010 [cited by applicant]
US 8062273B2 · Weston · 2011 [cited by applicant]
US 8216198B2 · Heagle et al. · 2012 [cited by applicant]
US 8251979B2 · Malhi · 2012 [cited by applicant]
US 8257327B2 · Blott et al. · 2012 [cited by applicant]
US 8398614B2 · Blott et al. · 2013 [cited by applicant]
US 8449509B2 · Weston · 2013 [cited by applicant]
US 8529548B2 · Blott et al. · 2013 [cited by applicant]
US 8535296B2 · Blott et al. · 2013 [cited by applicant]
US 8551060B2 · Schuessler et al. · 2013 [cited by applicant]
US 8568386B2 · Malhi · 2013 [cited by applicant]
US 8679081B2 · Heagle et al. · 2014 [cited by applicant]
US 8834451B2 · Blott et al. · 2014 [cited by applicant]
US 8926592B2 · Blott et al. · 2015 [cited by applicant]
US 9017302B2 · Vitaris et al. · 2015 [cited by applicant]
US 9198801B2 · Weston · 2015 [cited by applicant]
US 9211365B2 · Weston · 2015 [cited by applicant]
US 9289542B2 · Blott et al. · 2016 [cited by applicant]
US 20020077661A1 · Saadat · 2002 [cited by applicant]
US 20020115951A1 · Norstrem et al. · 2002 [cited by applicant]
US 20020120185A1 · Johnson · 2002 [cited by applicant]
US 20020143286A1 · Tumey · 2002 [cited by applicant]
US 20100022990A1 · Karpowicz · 2010 [cited by examiner]
US 20130211318A1 · Croizat · 2013 [cited by examiner]
US 20140005618A1 · Locke · 2014 [cited by examiner]
US 20140163491A1 · Schuessler et al. · 2014 [cited by applicant]
US 20150080788A1 · Blott et al. · 2015 [cited by applicant]
US 20150290364A1 · Wall · 2015 [cited by examiner]
US 20160262672A1 · Hammond · 2016 [cited by examiner]
AU 550575B2 · 1986 [cited by applicant]
AU 745271B2 · 2002 [cited by applicant]
AU 755496B2 · 2002 [cited by applicant]
CA 2005436A1 · 1990 [cited by applicant]
DE 2640413A1 · 1978 [cited by applicant]
DE 4306478A1 · 1994 [cited by applicant]
DE 29504378U1 · 1995 [cited by applicant]
EP 0100148A1 · 1984 [cited by applicant]
EP 0117632A2 · 1984 [cited by applicant]
EP 0161865A2 · 1985 [cited by applicant]
EP 0358302A2 · 1990 [cited by applicant]
EP 1018967A1 · 2000 [cited by applicant]
GB 692578A · 1953 [cited by applicant]
GB 2195255A · 1988 [cited by applicant]
GB 2197789A · 1988 [cited by applicant]
GB 2220357A · 1990 [cited by applicant]
GB 2235877A · 1991 [cited by applicant]
GB 2329127A · 1999 [cited by applicant]
GB 2333965A · 1999 [cited by applicant]
JP 4129536B2 · 2008 [cited by applicant]
SG 71559 · 2002 [cited by applicant]
WO 8002182A1 · 1980 [cited by applicant]
WO 8704626A1 · 1987 [cited by applicant]
WO 90010424A1 · 1990 [cited by applicant]
WO 93009727A1 · 1993 [cited by applicant]
WO 9420041A1 · 1994 [cited by applicant]
WO 9605873A1 · 1996 [cited by applicant]
WO 9718007A1 · 1997 [cited by applicant]
WO 9913793A1 · 1999 [cited by applicant]
WO 2019140441A2 · 2019 [cited by applicant]
WO 2019194883A1 · 2019 [cited by applicant]
WO 2020061334A1 · 2020 [cited by applicant]
International Search Report and Written Opinion Corresponding to Application No. PCT/IB2021/050255, mailed Apr. 8, 2021. [cited by applicant]
Louis C. Argenta, MD and Michael J. Morykwas, PHD; Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience; Annals of Plastic Surgery; vol. 38, No. 6, Jun. 1997; pp. 563-576. [cited by applicant]
Susan Mendez-Eatmen, RN; “When wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. [cited by applicant]
James H. Blackburn II, MD et al.: Negative-Pressure Dressings as a Bolster for Skin Grafts; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457; Lippincott Williams & Wilkins, Inc., Philidelphia, PA, USA. [cited by applicant]
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. [cited by applicant]
S.E. Greer, et al. “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), 53, pp. 484-487. [cited by applicant]
George V. Letsou, MD., et al; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639. [cited by applicant]
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. [cited by applicant]
International Search Report for PCT International Application PCT/GB95/01983; Nov. 23, 1995. [cited by applicant]
PCT International Search Report for PCT International Application PCT/GB98/02713; Jan. 8, 1999. [cited by applicant]
PCT Written Opinion; PCT International Application PCT/GB98/02713; Jun. 8, 1999. [cited by applicant]
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; Jan. 15, 1998 & Apr. 29, 1997. [cited by applicant]
PCT Written Opinion, PCT International Application PCT/GB96/02802; Sep. 3, 1997. [cited by applicant]
Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. [cited by applicant]
Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. [cited by applicant]
Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. [cited by applicant]
Yusupov. Yu.N., et al; “Active Wound Drainage”, Vestnki Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. [cited by applicant]
Davydov, Yu.A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirugi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. [cited by applicant]
Davydov, Yu.A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page Engli… [cited by applicant]
Chariker, Mark E., M.D., et al; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. [cited by applicant]
Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. [cited by applicant]
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, pp. 2. [cited by applicant]
Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. [cited by applicant]
Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. [cited by applicant]
Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., No. 19, 1985, pp. 211-213. [cited by applicant]
Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. [cited by applicant]
Svedman, P. et al: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous of Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. [cited by applicant]
N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (… [cited by applicant]
K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), … [cited by applicant]
G. Živadinovi?, V. ?uki?, Ž. Maksimovi?, ?. Radak, and P. Peška, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (certified translation). [cited by applicant]
F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. [cited by applicant]
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1… [cited by applicant]
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. [cited by applicant]
D.E. Tribble, An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery 105 (1972) pp. 511-513. [cited by applicant]
M.J. Morykwas, L.C. Argenta, E.I. Shelton-Brown, and W. McGuirt, “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997), pp. 553… [cited by applicant]
C.E. Tennants, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. [cited by applicant]
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96… [cited by applicant]
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R… [cited by applicant]
V.A. Kuznetsov & N.a. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Mos… [cited by applicant]
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). [cited by applicant]
V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians; Jul. 2007. [cited by applicant]